Arterial thrombosis and cancer: the neglected side of the coin of Trousseau syndrome.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed.

1. Trousseau's syndrome with cerebral infarction as the first manifestation.American journal of translational research · 2026
   Article
2. Inconsistent and Inaccurate Cancer Clinical Trial Reporting of Venous and Arterial Thrombotic Events: An Urgent Call to Action.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
   Article
3. Myocardial infarction and pulmonary embolism in pancreatic cancer: a case report of two manifestations of Trousseau's syndrome.Frontiers in cardiovascular medicine · 2025
   Article
4. Cancer-associated thoracic aorta arterial thrombosis: case report and review of the literature.Frontiers in cardiovascular medicine · 2025
   Article
5. Thrombosis in myeloproliferative neoplasms: a viewpoint on its impact on myelofibrosis, mortality, and solid tumors.Blood cancer journal · 2024
   Review
6. Incidence and Risk Factors for Arterial Thrombosis in Patients with Acute Leukemia and Lymphoid Malignancies: A Retrospective Single-Center Study.Cancers · 2024
   Article
7. Arterial Thrombosis in Patients with Cancer.Cancers · 2024
   Review
8. Anticoagulation for the Prevention of Arterial Thrombosis in Ambulatory Cancer Patients: Systematic Review and Meta-Analysis.JACC. CardioOncology · 2023
   Article
9. To Anticoagulate or Not to Anticoagulate to Prevent Arterial Thrombosis During Systemic Cancer Therapy.JACC. CardioOncology · 2023
   Article
10. Association between cancer history and second-generation drug-eluting stent thrombosis: insights from the REAL-ST registry.Thrombosis journal · 2023
    Article
11. Old is new again: emergence of thromboembolic complications in cancer patients on immunotherapy.Thrombosis research · 2022
    Review
12. Role of von Willebrand factor in venous thromboembolic disease.JVS-vascular science · 2022
    Review
13. Cardiogenic shock among cancer patients.Frontiers in cardiovascular medicine · 2022
    Review
14. Medical and Neurological Management of Brain Tumor Complications.Current neurology and neuroscience reports · 2021
    Review
15. Non-bacterial thrombotic endocarditis manifested by ventricular fibrillation in a patient with low grade ovarian carcinoma: case report and literature review.European heart journal. Case reports · 2021
    Article
16. Extragastrointestinal stromal tumor in the rectovaginal septum associated with acute arterial occlusion.Gynecologic oncology reports · 2020
    Article
17. Importance of Standard Treatment in Prognosis of Patients with Ovarian Cancer and Associated Cerebral Infarction.Clinical interventions in aging · 2020
    Article
18. Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study.Leukemia · 2019
    Article

Corrections and comments

• Comment on
  Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer.2018

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as